Philippine Customs Investigates E-Cigarette Recycle and Resale Scandal

Jul.31.2024
Philippine Customs Investigates E-Cigarette Recycle and Resale Scandal
Customs bureau in the Philippines investigates the recycling and reselling of confiscated e-cigarette products, led by Commissioner Bienvenido Rubio.

According to a report by The Manila Times on July 31st, the Bureau of Customs (BoC) in the Philippines ordered an investigation on Tuesday (30th) into an incident involving the alleged recycling and reselling of confiscated e-cigarette products.


Customs Director General Bienvenido Rubio has instructed Deputy Director of the Intelligence Unit Juvymax Uy to lead a comprehensive investigation into these items. Reportedly, these e-cigarette products were recently seized and placed under a "custody order" through mission commands.


Currently, the number of e-cigarettes is still being verified.


Rubio added that the directive also aims to identify any actions that may involve personnel from the Customs Department. The investigation will assess any potential administrative and criminal responsibility pertaining to these allegations.


The group has been instructed to submit progress reports weekly and a detailed factual investigation report within 30 days.


At the same time, Rubio reassured the public that the counterfeit goods worth 11 billion pesos (1.8 billion dollars) recently confiscated in Binondo, Manila are safe.


He stated that these goods will be subject to appropriate detention and confiscation procedures in accordance with the Customs Modernization and Tariff Act and other relevant regulations.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Imperial Responds to 2Firsts: Disappointed by FDA Denial of blu Product
Imperial Responds to 2Firsts: Disappointed by FDA Denial of blu Product
2Firsts interviewed Imperial Brands on FDA’s blu denial. ITG Brands responded with disappointment, vowing to pursue a fair, science-based review.
Aug.22
Customs Officers Seize Large Shipment of Illegal Chinese Vapes in Sofia, Bulgaria
Customs Officers Seize Large Shipment of Illegal Chinese Vapes in Sofia, Bulgaria
Authorities in Sofia have seized 2,800 illegal disposable vapes, each containing 15ml of liquid—a total of 42,000ml—during an inspection at a logistics warehouse. The products, imported from China and disguised as waterproof sprays, far exceeded legal limits under Bulgarian law.
Aug.22 by 2FIRSTS.ai
Thai police seized 559,000 e-cigarettes worth $2.83 million, including INFY and Escobar brands
Thai police seized 559,000 e-cigarettes worth $2.83 million, including INFY and Escobar brands
Thai authorities seized 559,000 illicit e-cigarettes and parts, valued at around 90 million baht (≈$2.83 million), from a Saraburi warehouse. The haul included INFY and Escobar products. Suspects remain at large as the investigation continues.
Sep.11 by 2FIRSTS.ai
Dutch Ministry of Finance reports: Dutch tobacco tax revenue stagnates, mainly due to cross-border consumption shift
Dutch Ministry of Finance reports: Dutch tobacco tax revenue stagnates, mainly due to cross-border consumption shift
A report released by the Dutch Ministry of Finance indicates that tobacco tax increases have failed to boost fiscal revenue. The previously projected €7 million in revenue from a 5 cent per pack tax increase has now fallen to zero, primarily due to cross-border cigarette purchases. The current excise tax on cigarettes is €7.81 per pack, with no further increases planned. Tobacco tax revenue is projected to reach €2.5 billion in both 2025 and 2026.
Sep.24 by 2FIRSTS.ai
2Firsts Interview with IBVTA: UK Vape Tax May Weaken Harm Reduction Efforts
2Firsts Interview with IBVTA: UK Vape Tax May Weaken Harm Reduction Efforts
As the UK prepares to introduce its first-ever vape tax in 2026, questions are growing about how the measure will reshape the country’s harm reduction landscape. IBVTA tells 2Firsts that while it was not in favour of the new duty, it accepts that it is being implemented and is working with regulators to ensure a smooth rollout — warning, however, that higher costs could slow smokers’ transition to safer alternatives.
Oct.07
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai